Physician

Adil M Karamali, MD

According to 2025 Medicare claims, Adil Karamali, MD (NPI: 1811998297) practices interventional cardiology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is PROMEDICA NORTHWEST OHIO CARDIOLOGY CONSULTANTS, LLC (NPI: 1780820555; TIN: 263888045) and primary practice location at 43551-7121. Karamali is affiliated with the ProMedica Health Network, Inc. (ACO ID: A3016), Caravan Health ACO 50 LLC (ACO ID: A5160), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Karamali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,019 traditional Medicare patients, billed 1,721 HCPCS/CPT codes, and received $104,502 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,529 prescription claims across 911 beneficiaries totaling $919,954 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 13 claims. Open Payments data shows 23 records totaling $674. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $203,453 to $104,502. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $650,894 and ending at $919,954. For DME billing, reported payments moved sharply higher in recent years, from $7,381 to $28,619.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,444	3,369	$203,453
2016	1,531	3,311	$192,625
2017	1,343	2,712	$157,218
2018	1,216	2,665	$155,084
2019	1,268	2,834	$169,164
2020	1,064	2,059	$118,507
2021	1,100	1,925	$112,785
2022	1,060	1,730	$96,968
2023	897	1,481	$86,804
2024	1,019	1,721	$104,502

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	940	8,929	$650,894
2016	947	9,265	$739,623
2017	989	9,694	$862,408
2018	1,034	9,545	$1,152,670
2019	1,031	7,766	$1,037,374
2020	917	5,969	$728,074
2021	897	5,437	$795,859
2022	881	5,276	$790,404
2023	843	4,504	$751,363
2024	911	5,529	$919,954

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$2,573
2016	N/R	34	$1,855
2017	N/R	11	$604
2018	N/R	12	$48
2019	N/R	N/R	N/R
2020	N/R	13	$27,817
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	290	334	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	146	157	$61
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	417	430	$49
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	97	97	$14
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	97	97	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	342	16,535	$309,849
Entresto	Sacubitril/Valsartan	156	6,780	$149,498
Xarelto	Rivaroxaban	94	5,140	$93,841
Repatha Sureclick	Evolocumab	125	4,178	$81,049
Jardiance	Empagliflozin	92	4,260	$78,719

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$674	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adil M. Karamali, MD?

Tedicare shows public-source Medicare data for Adil M. Karamali, MD (NPI 1811998297), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adil M. Karamali, MD have ACO affiliation data?

Adil M. Karamali, MD is shown with ACO affiliation data for ProMedica Health Network, Inc. (MSSP, ACO ID A3016), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adil M. Karamali, MD?

Adil M. Karamali, MD is linked to PROMEDICA NORTHWEST OHIO CARDIOLOGY CONSULTANTS, LLC (billing NPI 1780820555) in the available physician profile data.

Does Adil M. Karamali, MD have Open Payments data?

Adil M. Karamali, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.